Ignite Creation Date:
2025-12-24 @ 4:12 PM
Ignite Modification Date:
2025-12-24 @ 4:12 PM
Study NCT ID:
NCT03947866
Status:
UNKNOWN
Last Update Posted:
2023-02-16
First Post:
2019-05-10
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Ezetimibe-Rosuvastatin Evaluation Study
Sponsor:
Elpen Pharmaceutical Co. Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-09-30
Start Date Type:
ACTUAL
Primary Completion Date:
2023-09-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-09-30
Completion Date Type:
ESTIMATED
First Submit Date:
2019-05-10
First Submit QC Date:
None
Study First Post Date:
2019-05-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-02-14
Last Update Post Date:
2023-02-16
Last Update Post Date Type:
ACTUAL